SG11202005822PA - Therapeutic agent for nervous system disease - Google Patents
Therapeutic agent for nervous system diseaseInfo
- Publication number
- SG11202005822PA SG11202005822PA SG11202005822PA SG11202005822PA SG11202005822PA SG 11202005822P A SG11202005822P A SG 11202005822PA SG 11202005822P A SG11202005822P A SG 11202005822PA SG 11202005822P A SG11202005822P A SG 11202005822PA SG 11202005822P A SG11202005822P A SG 11202005822PA
- Authority
- SG
- Singapore
- Prior art keywords
- therapeutic agent
- nervous system
- system disease
- disease
- nervous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017245133 | 2017-12-21 | ||
| JP2018156503 | 2018-08-23 | ||
| PCT/JP2018/046945 WO2019124483A1 (fr) | 2017-12-21 | 2018-12-20 | Agent pour le traitement d'une maladie du système nerveux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202005822PA true SG11202005822PA (en) | 2020-07-29 |
Family
ID=66993523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202005822PA SG11202005822PA (en) | 2017-12-21 | 2018-12-20 | Therapeutic agent for nervous system disease |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11369626B2 (fr) |
| EP (1) | EP3730144A4 (fr) |
| JP (3) | JP6650650B2 (fr) |
| CN (1) | CN111511373A (fr) |
| AU (1) | AU2018390261B2 (fr) |
| CA (1) | CA3086220A1 (fr) |
| IL (1) | IL275479A (fr) |
| RU (1) | RU2020123957A (fr) |
| SG (1) | SG11202005822PA (fr) |
| TW (1) | TWI798320B (fr) |
| WO (1) | WO2019124483A1 (fr) |
| ZA (1) | ZA202004433B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018390261B2 (en) * | 2017-12-21 | 2023-03-16 | Nippon Zoki Pharmaceutical Co., Ltd. | Agent for treatment of nervous system disease |
| CN112826827A (zh) * | 2021-01-24 | 2021-05-25 | 华中科技大学同济医学院附属协和医院 | 甲钴胺在毒物诱导的脊髓变性样疾病中的应用 |
| WO2023004235A1 (fr) * | 2021-07-23 | 2023-01-26 | University Of Florida Research Foundation, Incorporated | Régulation du phénotype de macrophages pro-inflammatoires par conception d'hydrogel biofonctionnel |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3889844B2 (ja) * | 1997-02-10 | 2007-03-07 | 龍兒 梶 | 筋萎縮性側索硬化症治療剤 |
| US6121249A (en) * | 1998-07-01 | 2000-09-19 | Donald L. Weissman | Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins |
| CN1135973C (zh) * | 1999-01-18 | 2004-01-28 | 倪荣聪 | 蛋氨酸组合物在制备治疗心、脑血管疾病的药物中的应用 |
| US7226916B1 (en) | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
| DE60212365T2 (de) * | 2001-04-25 | 2007-05-31 | Cobalz Ltd., Chester | Medizinische zusammensetzungen zur behandlung oder vorbeugung eines funktionellen vitamin b12 mangels |
| AU2002322275A1 (en) * | 2001-06-20 | 2003-01-08 | Mayo Foundation For Medical Education And Research | Adenosyl-cobalamin fortified compositions |
| US6951658B1 (en) * | 2003-07-08 | 2005-10-04 | Pearson Research & Development Limited | Emu-based compositions for mental well-being and method of use |
| US20050032740A1 (en) * | 2003-08-06 | 2005-02-10 | Balaji Venkataraman | Vitamin compositions for the treatment and prevention of vascular disease and dementia |
| DE102005001479A1 (de) * | 2005-01-12 | 2006-07-20 | Synavit Gmbh | Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung |
| US20070178141A1 (en) * | 2005-09-07 | 2007-08-02 | Bebaas, Inc. | Vitamin B12 compositions |
| GB0723972D0 (en) * | 2007-12-07 | 2008-01-23 | Queen Mary & Westfield College | Use of vitamin B12 |
| US20120010264A1 (en) | 2009-03-26 | 2012-01-12 | Dainippon Sumitomo Pharma Co., Ltd. | Novel medicament for treating cognitive impairment |
| WO2011043136A1 (fr) | 2009-10-08 | 2011-04-14 | 国立大学法人名古屋大学 | Agent immunosuppresseur contenant une cellule souche mésenchymateuse issue du tissu adipeux, et utilisation associée |
| JPWO2011118795A1 (ja) * | 2010-03-26 | 2013-07-04 | 国立大学法人名古屋大学 | 損傷部治療用組成物 |
| US20130143812A1 (en) | 2010-05-27 | 2013-06-06 | Sekisui Medical Co., Ltd. | Anti-inflammatory drug |
| WO2012125020A1 (fr) | 2011-03-14 | 2012-09-20 | N.V. Nutricia | Méthode de traitement d'un traumatisme neurologique |
| CN102631667B (zh) * | 2012-04-19 | 2013-10-02 | 赵廷宝 | 促神经再生注射剂及其制备方法 |
| CN102772407B (zh) * | 2012-08-01 | 2014-09-17 | 岳茂兴 | 一种促进神经损伤修复的药物组合物及其应用 |
| AU2014239651A1 (en) | 2013-03-14 | 2015-10-15 | Pharmaceutical Productions Inc. | Method of treating vitamin B12 deficiency |
| US10130657B2 (en) * | 2015-02-13 | 2018-11-20 | John C. Hughes | Formulation, apparatus, and methods for treatment of brain trauma |
| CN104688763A (zh) * | 2015-03-11 | 2015-06-10 | 刘力 | 包括手性异构化合物的赖肌维药物组合物及其用途 |
| DK3427726T3 (da) | 2016-03-07 | 2023-05-15 | Univ Osaka | Ark med vedvarende lægemiddelfrigvelse til behandling af nerveskade |
| CN107595874B (zh) * | 2016-07-12 | 2020-10-30 | 石药集团恩必普药业有限公司 | 一种含有丁苯酞的药物组合物及其在制备治疗脑血管病药物中的应用 |
| CN106107388A (zh) * | 2016-07-31 | 2016-11-16 | 合肥远志医药科技开发有限公司 | 一种淡竹叶菊花植物饮料及其制作方法 |
| AU2018390261B2 (en) * | 2017-12-21 | 2023-03-16 | Nippon Zoki Pharmaceutical Co., Ltd. | Agent for treatment of nervous system disease |
-
2018
- 2018-12-20 AU AU2018390261A patent/AU2018390261B2/en active Active
- 2018-12-20 WO PCT/JP2018/046945 patent/WO2019124483A1/fr unknown
- 2018-12-20 RU RU2020123957A patent/RU2020123957A/ru unknown
- 2018-12-20 CA CA3086220A patent/CA3086220A1/fr active Pending
- 2018-12-20 TW TW107146170A patent/TWI798320B/zh active
- 2018-12-20 SG SG11202005822PA patent/SG11202005822PA/en unknown
- 2018-12-20 EP EP18892293.4A patent/EP3730144A4/fr active Pending
- 2018-12-20 JP JP2019554940A patent/JP6650650B2/ja active Active
- 2018-12-20 CN CN201880082317.0A patent/CN111511373A/zh active Pending
-
2020
- 2020-01-16 JP JP2020004921A patent/JP6708869B2/ja active Active
- 2020-04-07 JP JP2020068950A patent/JP6763533B2/ja active Active
- 2020-06-17 IL IL275479A patent/IL275479A/en unknown
- 2020-06-22 US US16/907,913 patent/US11369626B2/en active Active
- 2020-07-17 ZA ZA2020/04433A patent/ZA202004433B/en unknown
-
2022
- 2022-05-19 US US17/748,553 patent/US11679122B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6708869B2 (ja) | 2020-06-10 |
| US11679122B2 (en) | 2023-06-20 |
| CN111511373A (zh) | 2020-08-07 |
| TW201929871A (zh) | 2019-08-01 |
| US20220273692A1 (en) | 2022-09-01 |
| KR20200101948A (ko) | 2020-08-28 |
| IL275479A (en) | 2020-08-31 |
| ZA202004433B (en) | 2022-01-26 |
| JP6650650B2 (ja) | 2020-02-19 |
| US11369626B2 (en) | 2022-06-28 |
| TWI798320B (zh) | 2023-04-11 |
| US20210008092A1 (en) | 2021-01-14 |
| EP3730144A4 (fr) | 2021-09-01 |
| CA3086220A1 (fr) | 2019-06-27 |
| AU2018390261B2 (en) | 2023-03-16 |
| WO2019124483A1 (fr) | 2019-06-27 |
| JP2020117529A (ja) | 2020-08-06 |
| EP3730144A1 (fr) | 2020-10-28 |
| AU2018390261A1 (en) | 2020-08-06 |
| JP2020075931A (ja) | 2020-05-21 |
| US20230302040A1 (en) | 2023-09-28 |
| JPWO2019124483A1 (ja) | 2019-12-26 |
| JP6763533B2 (ja) | 2020-09-30 |
| RU2020123957A (ru) | 2022-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201709456D0 (en) | Therapeutic agents | |
| HUE045043T2 (hu) | Terápiás szerek neurodegeneratív betegségekre | |
| GB201603104D0 (en) | Therapeutic agents | |
| IL263188B (en) | Treatment for Parkinson's disease | |
| ZA202004433B (en) | Therapeutic agent for nervous system disease | |
| GB201716942D0 (en) | Therapeutic compounds | |
| IL281869A (en) | Medical factor for neurodegenerative disease | |
| IL273929A (en) | Therapeutic agents for neurodegenerative diseases | |
| GB201700553D0 (en) | Therapeutic agents | |
| EP3593771C0 (fr) | Système pour une thérapie neuroprotectrice pour le glaucome | |
| SG11201705915VA (en) | Therapeutic agent for ischemic diseases | |
| IL257740A (en) | Medicinal compounds for pain and their synthesis | |
| ZA201807944B (en) | Treatment for parkinson's disease | |
| GB201712394D0 (en) | Therapeutic compounds | |
| GB201712392D0 (en) | Therapeutic compounds | |
| GB201712388D0 (en) | Therapeutic compounds | |
| GB201712390D0 (en) | Therapeutic compounds | |
| GB201712395D0 (en) | Therapeutic compounds | |
| GB201712393D0 (en) | Therapeutic compounds | |
| HU5050U (hu) | Hõterápiás rendszer | |
| GB201702921D0 (en) | Therapeutic agent | |
| GB201702052D0 (en) | Therapeutic agents | |
| GB201702047D0 (en) | Therapeutic agents | |
| GB201701631D0 (en) | Therapeutic agents | |
| GB201701570D0 (en) | Therapeutic agents |